Article Information
History
- June 27, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maria Kristina Parr1,*,
- Gabriella Ambrosio1,
- Bernhard Wuest2,
- Monica Mazzarino3,
- Xavier de la Torre3,
- Francesca Sibilia3,
- Jan Felix Joseph1,4,
- Patrick Diel5 and
- Francesco Botrè3,6
- 1Institute of Pharmacy, Freie Universität Berlin, Germany
- 2Agilent Technologies, Santa Clara CA, USA
- 3Laboratorio Antidoping FMSI, Rome, Italy
- 4Core Facility BioSupraMol, Department of Biology, Chemistry, Pharmacy, Freie Universitaet Berlin, Germany
- 5Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany
- 6Department of Experimental Medicine, ‘Sapienza’ University of Rome, Italy
- ↵*Corresponding Author: Prof. Dr. Maria Kristina Parr, Freie Universität Berlin, Institute of Pharmacy, Königin-Luise-Str. 2+4, 14195 Berlin, Germany, fon +49(0)30 838 57 686, fax +49(0)30 838 457 686, maria.parr{at}fu-berlin.de